Atezolizumab Immunotherapy in Patients With Advanced NSCLC

NCT03102242 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Atezolizumab

Sponsor

Alliance Foundation Trials, LLC.